Usana Health Sciences
USNA
198 hedge funds and large institutions have $1.12B invested in Usana Health Sciences in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 60 increasing their positions, 69 reducing their positions, and 22 closing their positions.
41% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 22
27% more capital invested
Capital invested by funds: $882M → $1.12B (+$240M)
4% more funds holding
Funds holding: 191 → 198 (+7)
1.04% more ownership
Funds ownership: 54.24% → 55.29% (+1%)
13% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 69
30% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $1.45M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.6M |
| 2 |
BlackRock
New York
|
+$8.23M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.13M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$4.55M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.74M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$14.1M |
| 2 |
Goldman Sachs
New York
|
-$7.55M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$5.87M |
| 4 |
Lazard Asset Management
New York
|
-$4.92M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.72M |
USNA Hedge Fund Activity: Q1 2021 in Review
198 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2021, worth a combined $1.12B — up 27% from $882M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new USNA positions and 22 closed out — a net gain of 9 holders — while 60 added to existing stakes and 69 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $27.6M. The largest seller was Renaissance Technologies, cutting an estimated $14.1M.
- 198 institutional investors held Usana Health Sciences (USNA) as of Q1 2021, up from 191 in Q4 2020.
- Funds reported $1.12B of Usana Health Sciences stock for Q1 2021, up 27% quarter-over-quarter.
- 31 funds opened new Usana Health Sciences positions in Q1 2021 and 22 closed out, a net change of +9 holders.
- The largest Usana Health Sciences buyer in Q1 2021 was Wellington Management Group, an estimated $27.6M added.
- The largest Usana Health Sciences seller in Q1 2021 was Renaissance Technologies, an estimated $14.1M sold.
Based on aggregated 13F filings for Q1 2021.